Close Menu

As sequencing becomes ever cheaper, genome profiling will move from being used in the clinic in cases of rare diseases to more everyday health issues, says Amy Dockser Marcus in The Wall Street Journal. "Whole-genome sequencing will not stay confined to extremely rare cases of obscure diseases," says Robert Green from Brigham and Women's Hospital and Harvard Medical School.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.